Conmed (MEX:CNMD) Institutional Ownership: 83.13% (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:CNMD Conmed Corp MEX:CNMD
80 GF Score
Price MXN720.00
GF Value MXN989.85
! 3 Warning Signs
View Full Analysis

What is Conmed Institutional Ownership?

Conmed MEX:CNMD 80 Institutional Ownership is 83.13% as of Sep. 02, 2026. GuruFocus rates MEX:CNMD with a GF Score™ of 80/100 and a GF Value™ of MXN989.85. The stock has 3 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Conmed's institutional ownership is 83.13%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Conmed's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Conmed's Float Percentage Of Total Shares Outstanding is 84.14%.

Conmed Institutional Ownership Historical Data

* Premium members only.

The historical data trend for Conmed's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Conmed Institutional Ownership Chart

Conmed Historical Data

The historical data trend for Conmed can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 77.69 76.74 72.90 72.76 74.64 74.82 76.33 76.26 82.94 83.13
MEX:CNMD
80GF Score
Conmed Corp MEX:CNMD
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Conmed Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 83.13% mean?
Conmed (MEX:CNMD) has a Institutional Ownership of 83.13% as of Sep. 02, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Conmed and its competitors.
Is Conmed's Institutional Ownership too high?
Conmed's current Institutional Ownership is 83.13%. Overall, Conmed has a GF Score™ of 80/100, reflecting its overall financial health beyond just this single metric.
How does Conmed's Institutional Ownership compare to TNDM and ATEC?
Conmed's Institutional Ownership of 83.13% can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Medical Devices & Instruments company?
A good Institutional Ownership depends on the Medical Devices & Instruments industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on Conmed and its competitors. Conmed's current Institutional Ownership is 83.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Conmed stock overvalued right now?
Conmed (MEX:CNMD) has a current Institutional Ownership of 83.13%. The stock's GF Value™ is MXN989.85, compared to a current price of MXN720.00 — trading 27.3% below its estimated fair value. The current Institutional Ownership is 83.13%. Conmed's overall GF Score™ is 80/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For Conmed (MEX:CNMD), the current Institutional Ownership is 83.13% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Conmed (MEX:CNMD) Overvalued in 2026?

Based on GuruFocus' analysis, Conmed stock appears to be undervalued. The current stock price of MXN720.00 is trading 27.3% below its estimated GF Value™ of MXN989.85.

Key valuation signals for MEX:CNMD:

  • Institutional Ownership: 83.13%
  • GF Value™: MXN989.85 vs. price of MXN720.00 (27.3% below fair value)
  • GF Score™: 80/100 with 3 warning signs

No single metric tells the full story. See the MEX:CNMD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Conmed Business Description

Other Exchanges CNMD:USA
Address 11311 Concept Boulevard, Largo, FL, USA, 33773
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
80GF Score

Get the complete analysis for MEX:CNMD

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN720.00
Price
MXN989.85
GF Value